Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vestem logo — A biotechnology pioneer advancing bioveterinary cell therapi...

Vestem

A biotechnology pioneer advancing bioveterinary cell therapies and next-gen pharmaceuticals for pet treatments.

Founded 2002 Series Unknown Total: $24.00M Biopharma, Biotechnology

General Information

Company Name Vestem
Founded Year 2002
Industries Biopharma, Biotechnology
Funding Stage Series Unknown
Social

Get notified when Vestem moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vestem

Vestem is a biotechnology startup founded in 2002 with a focus on advancing bioveterinary cell therapies and next-gen pharmaceuticals for pet treatments. The company's slogan, "A biotechnology pioneer advancing bioveterinary cell therapies and next-gen pharmaceuticals for pet treatments," encapsulates its mission succinctly. The latest investment of RUB24.00M came from Moscow Seed Fund in a Venture Round on 11 January 2024. Vestem operates in the Biopharma and Biotechnology industries, positioning itself at the forefront of innovative solutions for pet healthcare. The company's development of new bioveterinary cell therapies for regenerative therapy and next-generation pharmaceuticals marks its dedication to advancing the field of pet treatments.

Taxonomy: veterinary medicine, cell therapies, regenerative therapy, pharmaceuticals, pet treatments, animal health, biomedical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
11 Jan 2024

Vestem Alternatives & Competitors

Vestem vs
Shandong Luoxin Pharmaceutical Group Stock Co.,Ltd.
Shandong Luoxin Pharmaceutical Group Stock Co.,Ltd. China

1 Cefalexin Capsules 2 Cefradine Capsules 3 Cefixime Tablets 4 Cefotiam Hydrochloride for Inje...

278 employees
Health Care, Pharmaceutical
Vestem vs
FarmSteady
FarmSteady

Empowering food lovers to create artisanal foods at home with easy-to-use DIY kits. Discover the joy...

3 employees
Vestem vs
Click.in
Click.in

Online Classifieds for India. Online Classifieds for India. Online Classifieds for India. Online Cla...

Seed
2 employees
Advertising, Internet

FAQ About Vestem

A biotechnology pioneer advancing bioveterinary cell therapies and next-gen pharmaceuticals for pet treatments.
Vestem was founded in 2002.
Vestem operates in the following industries: Biopharma, Biotechnology.
Vestem has completed 1 funding round, raising a total of $24.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Vestem include Shandong Luoxin Pharmaceutical Group Stock Co.,Ltd., FarmSteady, Click.in, Gossamer, Bulwark Technologies LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vestem and Shandong Luoxin Pharmaceutical Group Stock Co.,Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vestem and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy